Drug-Development Challenges for Small Biopharmaceutical Companies

N Engl J Med. 2017 Feb 2;376(5):469-474. doi: 10.1056/NEJMra1510070.
No abstract available

Publication types

  • Review

MeSH terms

  • Biomarkers / analysis
  • Clinical Trials as Topic / economics
  • Clinical Trials as Topic / standards*
  • Commerce
  • Drug Discovery*
  • Drug Industry*
  • Genetic Markers
  • Historically Controlled Study
  • Humans
  • Kaplan-Meier Estimate
  • Placebo Effect

Substances

  • Biomarkers
  • Genetic Markers